Inventor · disambiguated record
Ciaran Daniel Scallan
Also filed as: SCALLAN CIARAN · SCALLAN CIARAN DANIEL
8 granted patents·24 pending applications·7 citations·filing 2010–2025
80Inventor score
Top patents by PatentIndex Score
32 records- 0189US12109257B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Oct 8, 2024·1 cites·20 claims
- 0289US11591619B2Modified adenovirusesGRITSTONE BIO INC·Filed 2021·Granted Feb 28, 2023·1 cites·41 claims
- 0388US11771747B2Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2022·Granted Oct 3, 2023·2 cites·23 claims
- 0488US11510973B2Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Nov 29, 2022·1 cites·57 claims
- 0583US2025249084A1Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0680US11504421B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2018·Granted Nov 22, 2022·1 cites·30 claims
- 0779US12098383B2Modified adenovirusesGRITSTONE BIO INC·Filed 2023·Granted Sep 24, 2024·0 cites·35 claims
- 0879US2025236884A1Modified adenovirusesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0978US2025082784A1Formulations for small intestinal delivery of rsv and norovirus antigensVAXART INC·Filed 2024·Application pending·0 cites
- 1074US12186407B2Formulations for small intestinal delivery of RSV and norovirus antigensVAXART INC·Filed 2022·Granted Jan 7, 2025·0 cites·13 claims
- 1173US11433146B2Formulations for small intestinal delivery of RSV and norovirus antigensVAXART INC·Filed 2016·Granted Sep 6, 2022·1 cites·16 claims
- 1271US2024067985A1Viral delivery of neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 1369US2025025544A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1469US2023128001A1Hiv antigens and mhc complexesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1568US2025270589A1Viral delivery of neoantigensSEATTLE PROJECT CORP·Filed 2025·Application pending·0 cites
- 1667US2024285739A1Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 1763US2024238412A1Pancoronavirus vaccinesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1862US2022265812A1Hiv antigens and mhc complexesGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 1959US2025121052A1Sars-cov-2 vaccinesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 2059US2023310563A1Antigen-encoding cassettesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2158US2023020089A1Shared neoantigen vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2258US2023303614A1Capping compounds, compositions and methods of use thereofGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2357US2023047979A1Durable vaccinationGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2457US2024050550A1Infectious disease antigens and vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2557US2023330215A1Sars-cov-2 vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2656US2021213122A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2753US2024093235A1Homologous adenoviral vaccinationGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 2848US2020010849A1Viral delivery of neoantigensGRITSTONE ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 2944US2025276049A1Egfr vaccine cassettesGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 3042US2025269002A1Cta vaccine cassettesGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 3137US2017298389A1Hsv vaccinesVAXART INC·Filed 2015·Application pending·0 cites
- 3232US2012244185A1Immunization strategy to prevent h1n1 infectionTUCKER SEAN N·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ciaran Daniel Scallan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →